12, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, announced it will offer compounded GLP-1 injections paired with Nooms powerful GLP-1 companion program, providing a sustainable pathway off the medications
Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist that helps with weight loss by slowing gastric emptying, controlling appetite, and regulating blood sugar
scores below these thresholds were considered as low expression
Every batch of LiveWell Tirzepatide is third-party tested and ships with a Certificate of Analysis (COA), typically 99%+ purity by HPLC
Tirzepatide in PCOS: menstrual regularity and insulin resistance outcomes
Other research suggests that GLP-1s may help reduce thromboembolic events, such as deep vein thrombosis (DVT), in people with obesity and autoimmune diseases